In Vivo Toxicology

Global In Vivo Toxicology Market to Reach US$9.5 Billion by 2030

The global market for In Vivo Toxicology estimated at US$6.5 Billion in the year 2024, is expected to reach US$9.5 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$6.8 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 9.9% CAGR

The In Vivo Toxicology market in the U.S. is estimated at US$1.7 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 9.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global In Vivo Toxicology Market - Key Trends and Drivers Summarized

Why Is In Vivo Toxicology Key in Drug Development and Safety Testing?

In vivo toxicology is a vital component of drug development, focusing on assessing the safety and potential adverse effects of drug candidates when administered to living organisms. Toxicology studies are necessary to determine the dosage at which a substance becomes harmful and to evaluate the risk of long-term exposure. These studies are required by regulatory authorities to ensure that new drugs are safe before they can proceed to human clinical trials. In vivo toxicology is not only crucial in pharmaceuticals but also in testing chemicals, pesticides, and other substances that could affect human health, making it a cornerstone of safety evaluation across various industries.

How Are Technological Innovations Impacting the In Vivo Toxicology Market?

Technological advancements are transforming in vivo toxicology by improving the accuracy, efficiency, and ethical standards of animal testing. High-throughput screening methods, combined with advanced imaging technologies such as MRI and fluorescence imaging, allow for more detailed and non-invasive monitoring of toxic effects in real time. Additionally, developments in gene editing, such as CRISPR-Cas9, have enabled the creation of more precise animal models that better mimic human diseases, leading to more accurate toxicity assessments. Efforts to reduce the use of animal testing have also led to the integration of in vitro methods and computational toxicology, allowing researchers to refine, reduce, and replace animal models where possible, in line with ethical considerations.

How Do Market Segments Define the In Vivo Toxicology Market?

Testing types include acute, sub-chronic, and chronic toxicity studies, with chronic toxicity studies being the most significant segment due to the need for long-term safety assessments. Applications of in vivo toxicology span across pharmaceuticals, chemicals, cosmetics, and food additives, with pharmaceuticals leading the market as toxicology testing is a critical step in drug development. End-users include pharmaceutical companies, contract research organizations (CROs), and regulatory agencies, with CROs playing an increasingly prominent role due to the outsourcing of toxicology services. The market is also expanding in regions where regulatory standards for safety testing are becoming more stringent.

What Factors Are Driving the Growth in the In Vivo Toxicology Market?

The growth in the in vivo toxicology market is driven by several factors, including the increasing demand for new drug development, stricter regulatory requirements, and technological advancements in testing methods. As pharmaceutical companies continue to develop innovative therapies, particularly in the fields of biologics and gene therapy, the need for comprehensive toxicology studies is rising. Regulatory agencies such as the FDA and EMA have implemented rigorous safety testing guidelines, driving the demand for in vivo toxicology to ensure compliance. Additionally, advancements in imaging, gene editing, and data analytics are enhancing the accuracy and efficiency of toxicology studies, further supporting market growth. Ethical considerations and the shift towards reducing animal testing are also influencing the evolution of the market.

SCOPE OF STUDY:

The report analyzes the In Vivo Toxicology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Component (Consumables, Instruments); Toxicity End Point (Immunotoxicity, Systemic toxicity, Carcinogenicity, Genotoxicity, Other Toxicity Endpoints)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Charles River Laboratories
• Danaher
• Data Sciences International
• Envigo
• Eurofins Scientific
• Labcorp
• Perkinelmer
• SRI International
• Taconic Biosciences
• The Jackson Laboratory
• Thermo Fisher Scientific
• Wuxi Apptec

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.